Literature DB >> 33880514

Long-term viability and extensibility of an in situ regenerated canine aortic wall using hybrid warp-knitted fabric.

Shintaro Nemoto1, Hayato Konishi1, Tatsuya Suzuki1, Ryo Shimada1, Takahiro Katsumata1, Satomi Osawa2, Ayuko Yamaguchi3.   

Abstract

OBJECTIVES: Many surgical materials promoting tissue regeneration have been explored for use in paediatric cardiac surgery. The aim of this study is to evaluate the long-term viability and extensibility of the canine aortic wall regenerated using a novel synthetic hybrid fabric.
METHODS: The sheet is a warp-knitted fabric of biodegradable (poly-l-lactic acid) and non-biodegradable (polyethylene terephthalate) yarns coated with cross-linked gelatine. This material was implanted as a patch to fill an oval-shaped defect created in the canine descending aorta. The tissue samples were explanted after 12, 24 or 36 months (N = 3, 2, 2, respectively) for histological examination and biomechanical testing.
RESULTS: There was no shrinkage, rupture or aneurysmal change after 24 months. The regenerated wall showed prototypical vascular healing without material degeneration, chronic inflammation, calcification or abnormal intimal overgrowth. Bridging tissue across the patch was well-formed and had expanded over time. The biodegradable yarns had completely degraded at 24 months after implantation, as scheduled, but the regenerated aortic wall demonstrated satisfactory levels of mechanical strength and extensibility in tensile strength tests.
CONCLUSIONS: The sheet achieved good long-term viability and extensibility in the regenerated aortic wall. These findings suggest that it is a promising surgical material for repairing congenital heart defects. Further developments of the sheet are required, including clinical studies.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Biodegradable polymer; Congenital cardiac surgery; Extensibility; Mechanical strength; Surgical material; Tissue regeneration

Mesh:

Substances:

Year:  2021        PMID: 33880514      PMCID: PMC8691562          DOI: 10.1093/icvts/ivab064

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  14 in total

1.  Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model.

Authors:  Simon P Hoerstrup; Ian Cummings Mrcs; Mario Lachat; Frederick J Schoen; Rolf Jenni; Sebastian Leschka; Stefan Neuenschwander; Dörthe Schmidt; Anita Mol; Christina Günter; Mathias Gössi; Michele Genoni; Gregor Zund
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

2.  Total cavopulmonary connection with a new bioabsorbable vascular graft: First clinical experience.

Authors:  Leo A Bockeria; Oleg Svanidze; Alex Kim; Konstantin Shatalov; Vladimir Makarenko; Martijn Cox; Thierry Carrel
Journal:  J Thorac Cardiovasc Surg       Date:  2017-02-07       Impact factor: 5.209

3.  Morphology and mechanisms of a novel absorbable polymeric conduit in the pulmonary circulation of sheep.

Authors:  Marieke Brugmans; Aurélie Serrero; Martijn Cox; Oleg Svanidze; Frederick J Schoen
Journal:  Cardiovasc Pathol       Date:  2018-10-25       Impact factor: 2.185

Review 4.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

5.  In situ tissue regeneration using a warp-knitted fabric in the canine aorta and inferior vena cava.

Authors:  Shintaro Nemoto; Hayato Konishi; Ryo Shimada; Tatsuya Suzuki; Takahiro Katsumata; Hideaki Yamada; Jun Sakurai; Yohei Sakamoto; Kazuteru Kohno; Atsuko Onishi; Masaya Ito
Journal:  Eur J Cardiothorac Surg       Date:  2018-08-01       Impact factor: 4.191

6.  First Successful Clinical Application of the In Vivo Tissue-Engineered Autologous Vascular Graft.

Authors:  Nobuyasu Kato; Masaaki Yamagishi; Keiichi Kanda; Takako Miyazaki; Yoshinobu Maeda; Masashi Yamanami; Taiji Watanabe; Hitoshi Yaku
Journal:  Ann Thorac Surg       Date:  2016-10       Impact factor: 4.330

7.  In situ heart valve tissue engineering using a bioresorbable elastomeric implant - From material design to 12 months follow-up in sheep.

Authors:  Jolanda Kluin; Hanna Talacua; Anthal I P M Smits; Maximilian Y Emmert; Marieke C P Brugmans; Emanuela S Fioretta; Petra E Dijkman; Serge H M Söntjens; Renée Duijvelshoff; Sylvia Dekker; Marloes W J T Janssen-van den Broek; Valentina Lintas; Aryan Vink; Simon P Hoerstrup; Henk M Janssen; Patricia Y W Dankers; Frank P T Baaijens; Carlijn V C Bouten
Journal:  Biomaterials       Date:  2017-02-08       Impact factor: 12.479

8.  Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Authors:  Matthew P Brennan; Alan Dardik; Narutoshi Hibino; Jason D Roh; Gregory N Nelson; Xenophon Papademitris; Toshiharu Shinoka; Christopher K Breuer
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

9.  Late-term results of tissue-engineered vascular grafts in humans.

Authors:  Narutoshi Hibino; Edward McGillicuddy; Goki Matsumura; Yuki Ichihara; Yuji Naito; Christopher Breuer; Toshiharu Shinoka
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02       Impact factor: 5.209

Review 10.  Current Challenges in Translating Tissue-Engineered Heart Valves.

Authors:  O M J A Stassen; D E P Muylaert; C V C Bouten; J Hjortnaes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.